Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MT-3724 |
Trade Name | |
Synonyms | MT3724 |
Drug Descriptions |
MT-3724 is a cytotoxic antibody that targets CD20-expressing cells, which may block protein synthesis and induce apoptosis of tumor cells (PMID: 29559616). |
DrugClasses | CD20 Antibody 24 |
CAS Registry Number | NA |
NCIT ID | C120546 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + MT-3724 + Oxaliplatin | Gemcitabine MT-3724 Oxaliplatin | 0 | 1 |
Ibrutinib + MT-3724 | Ibrutinib MT-3724 | 0 | 0 |
Lenalidomide + MT-3724 | Lenalidomide MT-3724 | 0 | 1 |
MT-3724 | MT-3724 | 0 | 2 |
MT-3724 + Venetoclax | MT-3724 Venetoclax | 0 | 0 |